A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at Stanford. Pumpalova, Y. S., Kozak, M. M., von Eyben, R., Fisher, G. A., Kunz, P. L., Chang, D., Haraldsdottir, S. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.4_suppl.710

View details for Web of Science ID 000436174100686